AvantGuard Revenue and Competitors

Location

#7236

Growjo Ranking

Employee Data

  • AvantGuard has 22 Employees.(i)
  • AvantGuard grew their employee count by 10% last year.

AvantGuard's People

NameTitleEmail/Phone
1
Chief Technology OfficerReveal Email/Phone
2
VP Sales and MarketingReveal Email/Phone
3
VP Technical Product ManagementReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
N/A34712%N/AN/A
#2
$3.5M4146%$20MN/A
#3
N/A2210%$250KN/A
Add Company

What Is AvantGuard?

AvantGuard™, formerly Halomine, is revolutionizing the fight against harmful pathogens with our innovative technology that provides long-term protection against viruses, bacteria, and fungi/mold. Our proprietary combinations of specialty molecules and polymers are customized to deliver prolonged antimicrobial efficacy to a wide range of surfaces and materials, making them ideal for use in healthcare, food processing, and hospitality industries. Did you know that hospital-acquired infections and food-borne illnesses cost the world over $100B annually? Unlike current disinfectants that only offer temporary (15-minute) protection, AvantGuard's groundbreaking technology effectively holds chlorine from standard disinfectants on surfaces for as long as a month, extending the lifetime and overall utility of chlorine to continuously protect a variety of surfaces. Halomine Inc. was founded in 2018 as a Cornell University-based spin-out company. Since then, we have partnered with world-renowned universities, programs, incubators, and scientists to expand on our original research. We have also licensed N-halamine technology from both Cornell and Auburn University, where they have been working on N-halamine development for 30 years. Our technology has been recognized with several grants, awards, and partnerships with leading organizations in surface protection and beyond. Visit our website at https://www.avantguardinc.com/ to learn more about how AvantGuard can help protect you and your surfaces from harmful pathogens.

keywords:N/A

N/A

Total Funding

22

Number of Employees

N/A

Revenue (est)

10%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$2.2M22-8%N/A
#2
$1.6M22-8%N/A
#3
$3.5M2238%$3.6M
#4
$3.7M23-4%N/A
#5
$1.8M2377%N/A